News
T-Mobile's planned $4.4 billion acquisition of substantial UScellular assets has been approved by the US Department of ...
Researchers from Singapore University of Technology and Design (SUTD) have leveraged their expertise in microfluidics to ...
42m
Zacks Small Cap Research on MSNNNVC: NanoViricides Set to Initiate Phase 2 Trial in MPoxNNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...
The alliance brings together Cellular Origins, a company focusing on applying robotics and other forms of automation to CGT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results